Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,006,177,324
+$543,918,458 QoQ
Shares Held
59,086,417
-0.1% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#5
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. JNJ ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,006,177,324 | 59,086,417 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $14,462,258,866 | 59,164,862 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,993,527,940 | 57,953,747 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $10,423,469,665 | 56,215,455 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $9,258,097,458 | 60,609,476 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $9,848,209,391 | 59,383,800 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,339,934,590 | 57,667,920 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,092,681,620 | 56,106,884 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,053,726,004 | 55,102,121 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $8,435,159,675 | 53,322,964 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,033,988,480 | 51,256,785 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,326,795,238 | 47,042,024 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,225,979,524 | 49,697,798 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,549,662,500 | 48,707,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,471,883,686 | 47,958,583 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,786,376,664 | 47,663,912 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,291,049,567 | 46,707,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,979,168,597 | 45,021,546 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,596,467,702 | 44,405,610 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,996,305,324 | 43,320,776 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,954,372,579 | 42,214,232 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,709,628,358 | 40,825,241 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,312,370,944 | 40,109,105 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,887,135,636 | 39,542,824 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,565,254,634 | 39,573,737 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,109,500,905 | 38,965,156 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||